CBD
Medical Marijuana
Here's Why the DEA Re-Scheduling Just One Cannabis-Based Drug Is a Very Big Deal
For decades DEA has insisted marijuana has no legitimate use, even as it made research into medical marijuana nearly impossible. That contradiction is coming to an end.
More From This Topic
Pitching Investors
Blue Moon Hemp Wins Leafwire's Miami Pitch Contest
Pitch contests, long standard in traditional industries, give cannabis entrepreneurs the opportunity to meet investors.
News and Trends
Coca-Cola Is 'In Talks' to Make Marijuana-Infused Drinks
They're the latest beverage company to tap into the surging demand.
CBD
Report: CBD Market To Hit $22 Billion By 2022
Sales of the hemp-based compound will surpass those of legal cannabis.
CBD
Now that Epidiolex Is FDA Approved, What Does That Means for the CBD Business?
How to use the FDA's historic decision to your advantage.
CBD
How to Start and Market Your CBD Company
An immense market is developing quickly for CBD health and beauty products, including in states that have not legalized marijuana.
Video
This Week in Weed: The FDA and the Big3 Say "Yes" to Cannabis.
Introducing our new video series dedicated to keeping you highly informed.
Cannabis
Researchers Amazed by Cases of Cannabis Helping Children Failed by Conventional Medicine
A growing body of data is showing CBD, the active ingredient in medical marijuana, is a powerfully effective medicine for children suffering rare seizure disorders
Cannabis
New Customers Drive Innovation in Legal Marijuana Products
As marijuana moves from prohibition to a fragile but lucrative legal status it is attracting curious first time users interested in edibles but not bongs.
